GlassScriptPhysician profile
Julia V Oconnor
NPI 1477980712
$2,316.51
in general payments reported to CMS, 2019-2025
15 companies · $521 in 2025
The $521 reported for 2025 was more than what 75% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $291 · 2022: $471 · 2023: $478 · 2024: $556 · 2025: $521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,554.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $988.01 | 2021-2025 | Rybelsus, Ozempic |
| Glaxosmithkline, LLC. | $371.21 | 2021-2025 | Trelegy Ellipta, Shingrix |
| Astrazeneca Pharmaceuticals LP | $342.94 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Pfizer INC. | $107.97 | 2021-2025 | |
| Abbott Laboratories | $86.01 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Exact Sciences Corporation | $84.23 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Lilly USA, LLC | $73.71 | 2024-2025 | Mounjaro, Zepbound |
| Astellas Pharma US INC | $53.68 | 2023-2024 | Veozah, Myrbetriq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.88 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $49.59 | 2022 | |
| Abbvie INC. | $40.53 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.40 | 2021 | |
| Dexcom, INC. | $16.10 | 2022 | |
| Amgen INC. | $15.52 | 2022 | |
| Scpharmaceuticals INC. | $14.73 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Oconnor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.